The Use of TL Detectors in Dosimetry of Systemic Radiation Therapy

REFERENCES

• Strand S-E, Jonsson B-A, Ljungberg M, Tennvall J. Radioim-munotherapy dosimetry--a review. Acta Oncol 1993; 32: 807–17.
   PubMed Web of Science ®Google Scholar
• Chatal JF, Peltier P, Bardies M, et al. Does immunoscintigra-phy serve clinical needs effectively? Is there a future for radioimmunotherapy? Eur J Nucl Med 1992; 19: 205–13.
   PubMedGoogle Scholar
• Erdi AK, Erdi YE, Yorke ED, Wessels BW. Treatment planning for radio-immunotherapy. Phys Med Biol 1996; 41: 2009–26.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measure-ments. Methods of assessment of absorbed dose in clinical use of radionuclides. Washington, DC: ICRU Report No. 32, 1979.
   Google Scholar
• Loevinger R, Berman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1, Revised, New York: The Society of Nuclear Medicine, 1976.
   Google Scholar
• Snyder WS, Ford MR, Warner GG, Watson SB. '5', Ab-sorbed dose per unit cumulative activity for selected radionu-clides and organs. MIRD Pamphlet No. 11, New York: The Society of Nuclear Medicine, 1975.
   Google Scholar
• Watson EE, Stabin MG, Siegel JA. MIRD formulation. Med Phys 1993; 20: 511–4.
   PubMed Web of Science ®Google Scholar
• Giap HB, Macey DJ, Bayouth JE, Boyer AL. Validation of a dose-point kernel convolution technique for internal dosime-try. Phys Med Biol 1995; 40: 365–81.
   PubMed Web of Science ®Google Scholar
• Giap HB, Macey DJ, Podoloff DA. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy. J Nucl Med 1995; 36: 1885–94.
   Google Scholar
• Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiogra-phy with micro-TLD measurements for radioimmunotherapy. J Nucl Med 1988; 29: 1795–809.
   Google Scholar
• Wessels BW, Griffith MH. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models. J Nucl Med 1986; 27: 1308–14.
   PubMed Web of Science ®Google Scholar
• Strandh M, Strand S-E. In vivo absorbed dose measurements with mini-TLDs. Parameters effecting the reliability. Acta Oncol 1996; 35: 713–9.
   Google Scholar
• Strand S-E, Strandh M, Spanne P. Electron microscopy and computed microtomography studies of in vivo implanted mini-TL dosimeters. Acta Oncol 1993; 32: 787–91.
   Google Scholar
• Demidecki AJ, Williams LE, Wons SVC, et al. Considerations on the calibration of small thermoluminescent dosimeters used for measurement of beta particle absorbed doses in liquid environments. Med Phys 1993; 20: 1079–87.
   PubMed Web of Science ®Google Scholar
• Lampinen JS, Pohjonen HK, Savolainen SE. Calculating internal dose by convolution from SPECT/MR fusion images. Ann Nucl Med 1998; 12: 1–7.
   Google Scholar
• Bassi P, Busuoli G, Rimondi O. Calculated energy depen-dence of some RTL and RPL detectors. Int J of Appl Radiat Isot 1976; 27: 291–305.
   PubMedGoogle Scholar
• Hubbell JH. Photon mass attenuation and energy-absorption coefficients from 1 keV to 20 MeV. Int J Appl Radiat Isot 1982; 33: 1269–90.
   Google Scholar
• Nelson WR, Hirayama H, Rogers DWO. The EGS4 code system. Stanford Linear Accelerator Center Report SLAC-265; 1985.
   Google Scholar
• Kairemo KJA, Jekunen AP, Bondestam S, Korppi-Tommola ET, Savolainen S, Paavonen TK. Detection of pseudomyx-oma peritonei with radioimmunohistochemistry and radioim-munoscintigraphy. Cancer Biother Radiopharm 1996; 11: 325–34.
   Google Scholar
• Colcher D, Horan-Hand P, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3199–203.
   PubMed Web of Science ®Google Scholar
• Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D. Analysis of a human tumor-associated (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46: 850–7.
   PubMed Web of Science ®Google Scholar
• Watson EE, Stabin MG, Davis JL, Eckerman KF. A model of the peritoneal cavity for use in internal dosimetry. J Nucl Med 1989; 30: 2002–11.
   PubMedGoogle Scholar
• Stabin MG. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538–46.
   PubMed Web of Science ®Google Scholar
• Furhang EE, Sgouros G, Chui C-S. Radionuclide photon dose kernels for internal emitter dosimetry. Med Phys 1996; 23: 759–64.
   Google Scholar
• Larsson SA. Gamma camera emission tomography. Acta Radiol 1980; (Suppl 363): 75.
   Google Scholar
• Harris CC, Greer KL, Jaszczak RJ, Floyd CE Jr, Fearnow EC, Coleman RE. Tc-99m attenuation coefficient in water-filled phantoms determined with gamma cameras. Med Phys 1984; 11: 681–5.
   Google Scholar
• Christy M, Eckerman K. Specific absorbed fractions of en-ergy at various ages from internal photon sources. ORNL/ TM-8381. Oak Ridge, TN: Oak Ridge National Laboratory, 1987.
   Google Scholar
• Pohjonen HK, Savolainen SE, Nikkinen PH, Poutanen V-PO, Korppi-Tommola ET, Liewendahl BK. Abdominal SPECT/ MRI fusion applied to the study of splenic and hepatic uptake of radiolabeled thrombocytes and colloids. Ann Nucl Med 1996; 10: 409–17.
   Google Scholar
• Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med 1993; 34: 689–94.
   PubMed Web of Science ®Google Scholar
• Vriesendorp HM, Quadri SM, Andersson BS, Dicke KA. Hematologic side effects of radiolabeled immunoglobulin therapy. Exp Hematol 1996; 24: 1183–90.
   PubMedGoogle Scholar
• Bilski P, Olko P, Burgkhardt B, Piesch E, Waligorski MPR. Thermoluminescence efficiency of LiF:Mg,Cu,P (MCP-N) de-tectors to photons, beta electrons, alpha particles and thermal neutrons. Radiat Prot Dosim 1994; 55: 31–8.
   Google Scholar
• Horowitz YS, Shachar BB. Thermoluminescent LiF (Mg, Cu, P) for gamma ray dosimetry in mixed fast neutron-gamma ray radiation fields. Radiat Prot Dosim 1988; 23: 401–4.
   Google Scholar